Question 1

Has Stephanie Hamarman received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $59,910 in general payments to Stephanie Hamarman across 210 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Stephanie Hamarman did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Stephanie Hamarman come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie(2 entities)	141	$52,622
Sunovion Pharmaceuticals Inc.	18	$4,815
Alkermes, Inc.	31	$1,006
Validus Pharmaceuticals LLC	14	$862
E.r. Squibb & Sons, L.L.C.	3	$339
Avanir Pharmaceuticals, Inc.	2	$236
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$29

Stephanie Hamarman

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other psychiatry in New York